دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Effect of Clinical Decision Support With Audit and Feedback on Prevention of Acute Kidney Injury in Patients Undergoing Coronary AngiographyA Randomized Clinical Trial
Matthew T. James, MD, PhD; Bryan J. Har, MD, MPH; Benjamin D. Tyrrell, MD; et al.
doi : 10.1001/jama.2022.13382
September 6, 2022, Vol 328, No. 9, Pages 799-898
Effect of an Individualized Audit and Feedback Intervention on Rates of Musculoskeletal Diagnostic Imaging Requests by Australian General PractitionersA Randomized Clinical Trial
Denise A. O’Connor, PhD; Paul Glasziou, PhD; Christopher G. Maher, PhD; et al.
doi : 10.1001/jama.2022.14587
Association of Race and Ethnicity With Prescription of SGLT2 Inhibitors and GLP1 Receptor Agonists Among Patients With Type 2 Diabetes in the Veterans Health Administration System
Julio A. Lamprea-Montealegre, MD, MPH, PhD; Erin Madden, MPH; Sri Lekha Tummalapalli, MD, MBA, MAS; et al.
doi : 10.1001/jama.2022.13885
Racial Differences in Detection of Fever Using Temporal vs Oral Temperature Measurements in Hospitalized Patients
Sivasubramanium V. Bhavani, MD, MS; Zanthia Wiley, MD; Philip A. Verhoef, MD, PhD; et al.
doi : 10.1001/jama.2022.12290
Association Between Vaccination and Acute Myocardial Infarction and Ischemic Stroke After COVID-19 Infection
Young-Eun Kim, PhD; Kyungmin Huh, MD; Young-Joon Park, MD, MPH; et al.
doi : 10.1001/jama.2022.12992
Using Administrative Codes to Measure Health Care Quality
Jorge I. Portuondo, MD; Alex H. S. Harris, PhD; Nader N. Massarweh, MD, MPH
doi : 10.1001/jama.2022.12823
Achieving Diagnostic Equity in Cardiovascular Disease
Urmimala Sarkar, MD, MPH; Kirsten Bibbins-Domingo, PhD, MD, MAS
doi : 10.1001/jama.2022.14424
Clinical Decision Support to Prevent Acute Kidney Injury After Cardiac CatheterizationMoving Beyond Process to Improving Clinical Outcomes
Eric R. Gottlieb, MD, MS; Mallika Mendu, MD, MBA
doi : 10.1001/jama.2022.14070
Audit and Feedback—Optimizing a Strategy to Reduce Low-Value Care
Deborah Korenstein, MD; Erin F. Gillespie, MD
doi : 10.1001/jama.2022.14173
Beyond Detecting and Understanding Disparities in Novel Diabetes TreatmentNeed for a Major Shift in Pharmacoequity Research
Utibe R. Essien, MD, MPH; Donna L. Washington, MD, MPH; Michael J. Fine, MD, MSc
doi : 10.1001/jama.2022.13366
Diagnosis and Treatment of Myelodysplastic SyndromesA Review
Mikkael A. Sekeres, MD, MS; Justin Taylor, MD
doi : 10.1001/jama.2022.14578
Treatment of Clostridioides difficile Infection
Kanika Sehgal, MBBS; Adam S. Cifu, MD; Sahil Khanna, MBBS, MS
doi : 10.1001/jama.2022.12251
Serum Cystatin C for Estimation of GFR
Michael G. Shlipak, MD, MPH; Lesley A. Inker, MD, MS; Josef Coresh, MD, PhD
doi : 10.1001/jama.2022.12407
The US Now Has a Research Plan for Long COVID—Is It Enough?
Jennifer Abbasi
doi : 10.1001/jama.2022.14536
Large Autopsy Study Estimates Prevalence of “LATE� Neuropathologic Change
Emily Harris
doi : 10.1001/jama.2022.11513
Benefit of Dapagliflozin When Used With Cardiovascular Medications in Patients With Type 2 Diabetes
Anita Slomski
doi : 10.1001/jama.2022.14696
Weekend Warriors Reap Same Benefits as the Regularly Active
Anita Slomski
doi : 10.1001/jama.2022.14695
FDA Authorizes Intradermal Vaccine, Streamlines Rules to Increase Monkeypox Treatment Access
Howard D. Larkin
doi : 10.1001/jama.2022.14692
First Therapy Targeting ERBB2-Low Breast Cancer Approved
Howard D. Larkin
doi : 10.1001/jama.2022.14691
Improving Patient Communication on LASIK Benefits and Risks
Howard D. Larkin
doi : 10.1001/jama.2022.14767
Just the Plague: Reflections on State Control of Infectious Outbreaks
Georgios Pappas, MD
doi : 10.1001/jama.2022.0354
Mental Health and Substance Use Among US Homeless Adolescents
Kekoa Taparra, MD, PhD; Alana Egan, MA; Leimomi Kanagusuku, MD
doi : 10.1001/jama.2022.11622
Mental Health and Substance Use Among US Homeless Adolescents—Reply
Michael Liu, MPhil; Rishi K. Wadhera, MD, MPP, MPhil
doi : 10.1001/jama.2022.11625
Alirocumab Added to High-Intensity Statin Therapy and Coronary Atherosclerosis in Patients With Acute Myocardial Infarction
Victor M. Benson, MD
doi : 10.1001/jama.2022.11833
Alirocumab Added to High-Intensity Statin Therapy and Coronary Atherosclerosis in Patients With Acute Myocardial Infarction
Andrea Teira Calderón, MD; Jorge Sanz-Sánchez, MD, PhD; Hector M. Garcia-Garcia, MD, MSc, PhD
doi : 10.1001/jama.2022.11830
Alirocumab Added to High-Intensity Statin Therapy and Coronary Atherosclerosis in Patients With Acute Myocardial Infarction—Reply
Lorenz Räber, MD, PhD; Konstantinos C. Koskinas, MD
doi : 10.1001/jama.2022.11836
